Literature DB >> 22825318

Transdermal delivery of three vitamin C derivatives by Er:YAG and carbon dioxide laser pretreatment.

Chun-Hsun Huang1, Hsin-Ching Sung, Chien-Yu Hsiao, Sindy Hu, Yu-Shien Ko.   

Abstract

The objective of this study was to investigate the effects of two lasers (Er:YAG and CO2) in enhancing skin permeation of three vitamin C derivatives, L-ascorbic acid 2-phosphate sesquimagnesium salt (MAP-1), magnesium L-ascorbic acid-2-phosphate (MAP-2), and 2-phospho-L-ascorbic acid trisodium salt (SAP). Dorsal skin of 1-week-old pathogen-free pigs was used for this in vitro study. Changes in permeation in laser-treated skin treated by the lasers were examined by confocal scanning electron microscopy. Transdermal flux of vitamin C derivatives was examined with a Franz diffusion cell. Fluxes of MAP-1, MAP-2, and SAP across Er:YAG laser-treated skin were 15-27-fold, 48-123-fold, and 22-56-fold higher, respectively, than their fluxes across intact skin. The fluxes of MAP-1, MAP-2, and SAP across CO2 laser-treated skin were 28-36-fold, 116-156-fold, and 79-102-fold higher, respectively, than their fluxes across intact skin. Optimal fluency for the Er:YAG laser was 3.8 J/cm(2) for MAP-1 and 5 J/cm(2) for MAP-2 and SAP. Optimal fluency for the CO2 laser was 5 W for all three derivatives. In conclusion, optimal fluency for all derivatives was 5 W for the CO2 laser and 3.8 to 5 J/cm(2) for the Er:YAG laser.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22825318     DOI: 10.1007/s10103-012-1151-y

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  21 in total

1.  Skin pretreatment with an Er:YAG laser promotes the transdermal delivery of three narcotic analgesics.

Authors:  Woan-Ruoh Lee; Shing-Chuan Shen; Chia-Lang Fang; Ching-Ru Liu; Jia-You Fang
Journal:  Lasers Med Sci       Date:  2007-03-03       Impact factor: 3.161

2.  Fractional laser as a tool to enhance the skin permeation of 5-aminolevulinic acid with minimal skin disruption: a comparison with conventional erbium:YAG laser.

Authors:  Woan-Ruoh Lee; Shing-Chuan Shen; Man-Hui Pai; Hung-Hsu Yang; Cheng-Yin Yuan; Jia-You Fang
Journal:  J Control Release       Date:  2010-03-29       Impact factor: 9.776

3.  Erbium:YAG laser enhances transdermal peptide delivery and skin vaccination.

Authors:  Woan-Ruoh Lee; Tai-Long Pan; Pei-Wen Wang; Rou-Zi Zhuo; Chun-Ming Huang; Jia-You Fang
Journal:  J Control Release       Date:  2008-03-10       Impact factor: 9.776

4.  Skin pretreatment with lasers promotes the transdermal delivery of vitamin C derivatives.

Authors:  Chien-Yu Hsiao; Chun-Hsun Huang; Sindy Hu; Yu-Shien Ko; Hsin-Ching Sung; Shih-Yi Huang
Journal:  Lasers Med Sci       Date:  2010-12-01       Impact factor: 3.161

5.  In vivo model of histologic changes after treatment with the superpulsed CO(2) laser, erbium:YAG laser, and blended lasers: a 4- to 6-month prospective histologic and clinical study.

Authors:  D Greene; B M Egbert; D S Utley; R J Koch
Journal:  Lasers Surg Med       Date:  2000       Impact factor: 4.025

6.  The spectrum of laser skin resurfacing: nonablative, fractional, and ablative laser resurfacing.

Authors:  Macrene R Alexiades-Armenakas; Jeffrey S Dover; Kenneth A Arndt
Journal:  J Am Acad Dermatol       Date:  2008-05       Impact factor: 11.527

7.  Environmentally friendly LC for the simultaneous determination of ascorbic acid and its derivatives in skin-whitening cosmetics.

Authors:  Angel Balaguer; Alberto Chisvert; Amparo Salvador
Journal:  J Sep Sci       Date:  2008-02       Impact factor: 3.645

Review 8.  Cosmeceuticals: practical applications.

Authors:  Anetta E Reszko; Diane Berson; Mary P Lupo
Journal:  Dermatol Clin       Date:  2009-10       Impact factor: 3.478

9.  Topical ascorbic acid on photoaged skin. Clinical, topographical and ultrastructural evaluation: double-blind study vs. placebo.

Authors:  Philippe G Humbert; Marek Haftek; Pierre Creidi; Charles Lapière; Betty Nusgens; Alain Richard; Daniel Schmitt; André Rougier; Hassan Zahouani
Journal:  Exp Dermatol       Date:  2003-06       Impact factor: 3.960

10.  A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma.

Authors:  Liliana Elizabeth Espinal-Perez; Benjamin Moncada; Juan Pablo Castanedo-Cazares
Journal:  Int J Dermatol       Date:  2004-08       Impact factor: 2.736

View more
  3 in total

Review 1.  How physical techniques improve the transdermal permeation of therapeutics: A review.

Authors:  Yan Gao; Lina Du; Qian Li; Qi Li; Lin Zhu; Meiyan Yang; Xiu Wang; Bonian Zhao; Shan Ma
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

Review 2.  Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitors.

Authors:  Thanigaimalai Pillaiyar; Manoj Manickam; Vigneshwaran Namasivayam
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

Review 3.  Fermented broth in tyrosinase- and melanogenesis inhibition.

Authors:  Chin-Feng Chan; Ching-Cheng Huang; Ming-Yuan Lee; Yung-Sheng Lin
Journal:  Molecules       Date:  2014-08-26       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.